Search for: "Teva Pharmaceuticals"
Results 901 - 920
of 1,429
Sort by Relevance
|
Sort by Date
20 Jul 2011, 4:04 am
– Economic Times reports ‘Letter of Understanding’ between EU and India (Spicy IP) (Generic Pharmaceuticals and IP) France considers paralysing IP rights on the appearance of generic drugs (Class 46) India: Application of Orphan Drug Act to section 3(d)? [read post]
19 Jul 2011, 6:03 am
Here's the list for 2011 so far: Potential Signals of Serious Risks/New Safety Information Identified by AERS, January to March 2011 Product Potential Signal of a Serious Risk/New Safety Information Additional Information (as of May 31, 2011) … [read post]
18 Jul 2011, 5:16 pm
Circuit’s March 2, 2010 decision in Teva Pharmaceuticals USA, Inc. v. [read post]
13 Jul 2011, 3:04 am
(The SPC Blog) Doha+10: On November 14, 2011, a meeting at WIPO in Geneva to discuss the Doha Declaration (KEI) Docs at BIO: Session on IP challenges for personalised medicine (Patent Docs) France to reform its pharmaceutical regulatory system… with possible global implications! [read post]
6 Jul 2011, 2:21 am
Teva Pharms. [read post]
3 Jul 2011, 11:03 pm
After her death, Prewitt decided to sue the drugs' manufacturers and their distributors, which include Bayer, Barr Laboratories, Teva Pharmaceuticals and Intendis. [read post]
29 Jun 2011, 3:34 am
Sagent Pharmaceuticals, Inc. et al. [read post]
27 Jun 2011, 8:41 am
” Certiorari stage documents: Opinion below (3d Circuit) Petition for certiorari Brief in opposition Petitioners’ supplemental brief Respondents’ supplemental brief Petitioners’ reply Amicus brief of TEVA Pharmaceuticals USA, Inc. [read post]
24 Jun 2011, 3:25 pm
”Certiorari stage documents:Opinion below (3d Circuit)Petition for certiorariBrief in oppositionPetitioners' supplemental briefRespondents' supplemental briefPetitioners' replyAmicus brief of TEVA Pharmaceuticals USA, Inc.Amicus brief of Consumer Federation of America et al.Amicus brief of Mylan Pharmaceuticals, Inc.Amicus brief of Apotex, Inc.Amicus Generic Pharmaceutical AssociationCVSG Information:Invited: March 28, 2011Filed: May 26, 2011… [read post]
23 Jun 2011, 11:16 pm
Reddys Laboratories Mylan Pharmaceuticals Teva Aurobindo Pharma Glenmark Generics Lupin Wockhardt These companies and others are now allowed to sell their versions of Levaquin in the United States, which so far has earned $ 1.45 billion for a period of 12 months ending in September, 2010. [read post]
22 Jun 2011, 4:09 am
(BIOtechNow) US: Manager’s Amendment (and others) to H.R. 1249 — Second opinions in genetic diagnostic testing (Patent Docs) US: AMA, ACLU and their friends oppose (Leahy-Smith) America Invents Act (Patent Docs) US: Kaneka files new 337 complaint regarding Certain Coenzyme Q10 Products (ITC 337 Law Blog) Products Baytril (Enrofloxacin) – US: In a rare move, District Court extends 30-month stay on FDA ANADA approval: Bayer Healthcare v Norbrook (FDA Law Blog) Cialis (Tadalafil)… [read post]
17 Jun 2011, 2:25 am
The Bedford Report keeps an eye on healthcare companies and provides research reports on Teva Pharmaceutical Industries Limited (makers of generic Yasmin) and Mylan Inc., the makers of Effexor. [read post]
15 Jun 2011, 4:56 am
Par Pharmaceutical, Inc. [read post]
14 Jun 2011, 12:21 pm
Teva Pharmaceuticals USA, Inc., 10-1070, in which the Court had relisted twice and called for a response. [read post]
13 Jun 2011, 5:32 pm
(“APP”) and Sun Pharmaceuticals (“Sun”); however, all of these applicants submitted their applications subsequent to Teva’s ANDA submission. [read post]
7 Jun 2011, 12:30 pm
Teva Pharmaceuticals USADocket: 10-1070Issue(s): When a case becomes moot as the result of a third party’s independent action after the court of appeals issues a judgment but while a petition for rehearing is still pending, should the court of appeals vacate the judgment upon the request of the aggrieved party? [read post]
7 Jun 2011, 10:12 am
Teva Pharmaceuticals USA, Inc., 10-1070 (second relist since the Court called for a response). [read post]
2 Jun 2011, 12:46 pm
Ortho Pharmaceutical Corp., 681 P.2d 1038, 1052 (Kan. 1984). [read post]
2 Jun 2011, 6:02 am
Teva Pharmaceuticals USA, Inc., 10-1070, which we included in last week’s Petitions to Watch. [read post]
1 Jun 2011, 5:51 pm
Karst – Last week, in a seven-page response, FDA denied an October 18, 2010 Citizen Petition submitted on behalf of Lupin Limited (“Lupin”) requesting that FDA determine that Teva Pharmaceuticals USA, Inc. [read post]